Form 4 for CL Colgate-Palmolive
Accepted 2026-09-18 16:09:22 ET · period of report 2026-09-16 · accession 0001225208-26-007883 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 16:09 | 2026-09-16 | CL | Massey Sally | CHRO | A - Grant | $0.00 | +3,333 | 15.4K | +28% | $0 |
| D | 2026-09-18 16:09 | 2026-09-16 | CL | Massey Sally | CHRO | A - Grant | $0.00 | +23.1K | 23.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-16 | A | A | 3,333 | $0.00 | 15,397 | D | — | — | (F1) Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-09-16 | A | A | 23,065 | $0.00 | 23,065 | D | $87.02 · — to 2036-09-16 | 23,065 Common Stock | (F2) Stock option award granted under the issuer's incentive compensation plan. (F3) Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date. |